Search Results

Hollings Cancer Center, Medical University of South Carolina Beginning radiation therapy on time is critical for people with head and neck cancer. A multidisciplinary team at MUSC Hollings Cancer Center led by Evan Graboyes, MD, has spent five years bringing this issue to light and has now been awarded a $3.5 million grant to test an approach for reducing delays. Read More

Sylvester Comprehensive Cancer Center, University of Miami Researchers at Sylvester and collaborating organizations will study how new technology can help patients manage symptoms and related stress from cancer treatment while at home, under a five-year, $3.5 million grant from the National Institutes of Health. Read More

Stony Brook Cancer Center Researchers are trying to unlock the mysteries of how gliomas originate from normal cells. A new study centers on epigenetic rather than genetic changes that drive normal cells to form tumors. The work reveals the precise genes that are regulated epigenetically and lead to cancer. Read More

Hollings Cancer Center, Medical University of South Carolina E-cigarettes do have value as a smoking cessation aid, according to a new study by a team of MUSC Hollings Cancer Center researchers. The study, the largest trial of e-cigarettes in the U.S., showed that their usage nudged people toward quitting smoking – even those who entered the trial with no intention of quitting. Read More

Sylvester Comprehensive Cancer Center, University of Miami Researchers at the University of Miami's Sylvester Comprehensive Cancer Center said they have been awarded a $2.5 million grant from the National Cancer Institute to develop an exosome-based prostate cancer test. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center is pleased to announce the hiring of Dapo Amosu, MS, PharmD, DPLA, as its new senior director of pharmacy. Dr. Amosu has more than 25 years of pharmacy experience, with significant expertise in hematology/oncology pharmacy, clinical research, and pharmacy management. Read More

UK Markey Cancer Center While cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentucky and Appalachian Kentucky, according to a new UK Markey Cancer Center study. Read More

Comprehensive Cancer Center St. Jude Children's Research Hospital A recently published draft paper underlines the need for a more detailed molecular, histological, and clinical assessment of high-grade glioma tumors in infants and young children at diagnosis. Read More

Yale Cancer Center, Yale School of Medicine A common side effect of treatment for ovarian cancer is chemotherapy-induced peripheral neuropathy (CIPN). Currently, there is only one treatment with limited efficacy for CIPN. But new findings from a Phase III randomized clinical suggest that six months of an aerobic exercise intervention reduces CIPN symptoms. Read More

Huntsman Cancer Institute at the University of Utah An examination of the SCALE-UP Counts program, designed to promote COVID-19 testing through collaboration with local schools, especially those serving historically marginalized populations, was recently published. The analysis was led by Yelena Wu, PhD, and David Wetter, PhD, MS. Read More

Winship Cancer Institute of Emory University A team of researchers from Winship Cancer Institute and Case Western Reserve University has developed a method using artificial intelligence and machine learning to analyze imaging scans and determine whether a treatment for metastatic breast cancer will be effective. Read More

Stanford Cancer Institute A Stanford study shows that cancer cells can be prompted to activate cellular death, a finding that has therapeutic applications in cancer treatment, regenerative medicine, and developmental disorders. The study was led by Stanford Cancer Institute members Nathanael Gray, PhD, and Gerald Crabtree, MD. Read More

University of Florida Health Cancer Center A team of University of Florida medicinal chemists and cancer biologists has created a chemical compound that powerfully and selectively helped cells dispose of proteins that cause cancer cells to grow. Read More

The Tisch Cancer Institute at Mount Sinai Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset of ovarian cancer patients who are unlikely to respond to chemotherapy. Read More

UPMC Hillman Cancer Center Abby Overacre-Delgoffe, PhD, has received a $1.5 million National Institute of Allergy and Infectious Diseases New Innovator Award for her project, "Microbiota initiation of lymphangiogenesis." The award will fund research to better understand how gut bacteria drive the development of tertiary lymphoid structures. Read More

University of New Mexico Comprehensive Cancer Center The New Mexico Cancer Care Alliance has rebranded as the New Mexico Cancer Research Alliance to strengthen its focus on delivering cancer clinical trials to New Mexicans. The state's small population is spread over a large area, presenting a daunting challenge to offer clinical trials across the state. Read More

Comprehensive Cancer Center St. Jude Children's Research Hospital Scientists at St. Jude Children’s Research Hospital found immune and tumor cells compete over glutamine, a major nutrient in their local environment, with significant implications for anti-cancer activity. If cancer cells monopolize glutamine, they can prevent immune cells from destroying cancer. Read More

Karmanos Cancer Institute, Wayne State University Karmanos Cancer Institute welcomes Arnold D’Ambrosio as its new chief development officer. He brings the National Cancer Institute-designated comprehensive cancer center over 30 years of donor relations, fundraising, and major gifts experience. Read More

The University of Chicago Medicine Comprehensive Cancer Center University of Chicago Medicine Comprehensive Cancer Center researchers are using a new method they developed to accurately predict which patients with metastatic colorectal cancer will have a favorable treatment outcome following surgical removal of liver metastases. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Susan Tsai, MD, has been named the chief of the Division of Surgical Oncology at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. Read More

Roswell Park Comprehensive Cancer Center As work advances on a significant expansion of its cellular therapy production and research facilities, Roswell Park Comprehensive Cancer Center has named Yeong "Christopher" Choi, PhD, MBA, as senior vice president of industry partnerships and technical director of the center’s Current Good Manufacturing Practice facility. Read More

AACI will present the 2023 Public Service Awards to U.S. Representative Neal Dunn (R-FL) and U.S. Senator Amy Klobuchar (D-MN) on Monday, October 2, during the AACI/CCAF Annual Meeting at the Salamander Washington DC. Read More

Vanderbilt-Ingram Cancer Center Immune system T cells that should be able to kill cancer cells become dysfunctional or "exhausted" within hours of encountering a tumor, according to a new study. The surprising findings have implications for cancer immunotherapies that aim to harness the tumor-killing power of T cells. Read More

University of Colorado Cancer Center The University of Colorado Cancer Center is doubling down on its diversity, equity, inclusion, and access (DEIA) efforts, with the addition of DEIA Associate Director Miria Kano, PhD, and Deputy Associate Director Curtis Henry, PhD. Read More

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center Director of Radiation Research Anurag Singh, MD, has been named a 2023 American Society for Radiation Oncology (ASTRO) Fellow. ASTRO is the world’s largest society for radiation oncology professionals. Read More

With the end of the fiscal year approaching on September 30, Congress has not passed a Fiscal Year (FY) 2024 budget. To avert a shutdown, Congress must reach a bipartisan agreement to fund the government. AACI encourages you to write your Members of Congress today to urge them to pass the FY 2024 budget and to prioritize cancer research funding. Read More

Winship Cancer Institute of Emory University A new center at Winship Cancer Institute will focus research efforts on eliminating cancer disparities in Georgia and nationwide. Gifts from the Wilbur and Hilda Glenn Family Foundation and Southern Company are launching the Winship Center for Cancer Health Equity Research. Read More

This fall, AACI Clinical Research Innovation (CRI) will welcome Thomas J. George, Jr., MD, FACP, University of Florida Health Cancer Center, as the new CRI Steering Committee chair. CRI will also welcome three newly-elected members to the steering committee. They formally assume their duties in October during the 2023 AACI/CCAF Annual Meeting in Washington, DC. Pictured, clockwise from top left: Dr. Thomas J. George, Dina Aziz, Angela Campbell, and Dr. Muhammad Furquan. Read More

Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center has seven new research program leaders. Stacie Dusetzina, PhD, Eric Grogan, MD, MPH, and Daniel Barocas, MD, MPH, lead the Cancer Health Outcomes and Control Research Programs; Martha Shrubsole, PhD, co-leads the Cancer Epidemiology Research Program; Vandana Abramson co-leads the Breast Cancer Research Program; and Eben Rosenthal, MD, and Kristen Ciombor, MD, MSCI, lead the Translational Research and Interventional Oncology …

VCU Massey Cancer Center will present the 1st Annual Catchment Area Data (CADA) Conference: Beyond Definition, December 7-9, in Richmond, VA. The conference is open to AACI members and all eligible staff, faculty, students, and post-doc trainees from cancer centers who provide education, resources, and support within their defined catchment area. The early bird registration rate ends Friday, September 15. Read More

Comprehensive Cancer Center St. Jude Children's Research Hospital St. Jude Children’s Research Hospital will provide more than $50 million in funding to launch and implement six new groundbreaking projects. The initiatives were identified through the organization’s Blue-Sky program, which encourages the development of bold, transformational ideas by faculty and staff. Read More

Robert A. Winn, MD, director of VCU Massey Comprehensive Cancer Center, became AACI's president—the first person of color to hold the position—on October 3, at the conclusion of the 2023 AACI/CCAF Annual Meeting in Washington, DC. During the meeting, Dr. Winn announced plans for his AACI Presidential Initiative, which aims to develop and promote inclusive excellence through regional, national, and international partnerships. He succeeds Immediate Past President Caryn Lerman, PhD, director of th…

Joann B. Sweasy, PhD, a comprehensive cancer center director and an expert in the genetics, cell biology, and biochemistry of DNA repair, has been named the next director of the Fred & Pamela Buffett Cancer Center and the Eppley Institute for Research in Cancer and Allied Diseases. Dr. Sweasy is AACI's vice president/president-elect and served as director of the University of Arizona Cancer Center since 2019. Read More

The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI), the ultimate standard achieved by only 55 other NCI cancer centers in the U.S. As a result, MECCC was awarded a five-year, $20 million Cancer Center Support Grant. Edward Chu, MD, is the center's director and a member of AACI's 2023 Annual Meeting Program Committee. Read More

Richard Bold, MD, has been named site director of Mayo Clinic Comprehensive Cancer Center in Arizona. Dr. Bold joins Mayo Clinic from the University of California, Davis, where he has built an impressive career marked by excellence in patient care, innovative research, and dynamic leadership. Read More

Winship Cancer Institute of Emory University Suresh S. Ramalingam, MD, executive director of Winship Cancer Institute of Emory University, was awarded the Paul A. Bunn, Jr. Scientific Award at the 2023 IASLC World Conference on Lung Cancer. Read More

UK Markey Cancer Center has earned a National Cancer Institute (NCI) "Comprehensive" Cancer Center designation, the highest level of recognition awarded by the NCI. Markey received an initial NCI designation in 2013. The center is led by B. Mark Evers, MD. In addition to achieving Comprehensive status, Markey was awarded $13.5 million through a five-year renewal of its NCI Cancer Center Support Grant. Read More

Winship Cancer Institute of Emory University A three-year, $24.8 million cooperative agreement from the Advanced Research Projects Agency for Health will drive the development of a programmable approach to prevent, treat and potentially cure diseases including cancer. The funding supports work led by Winship member Philip Santangelo, PhD. Read More

Nearly 500 cancer center colleagues, exhibitors, and supporters, representing 97 AACI member centers, gathered in Washington, DC, for the 2023 AACI/CCAF Annual Meeting. It was the first time since 2019 that the nation’s capital was the venue for three-and-a-half days of networking, presentations, and panel discussions.   Read More

GW Cancer Center Lekhaj Daggubati, MD, MS, has joined the GW Cancer Center as director of Surgical Neuro-Oncology. He specializes in malignant and benign nervous system tumors, focusing on minimally invasive cranial approaches, laser interstitial thermal therapy, radiosurgery, and endoscopic neurosurgery. Read More

The University of Arizona Cancer Center The boisterous Rollies Mexican Patio in Tucson may seem an unlikely place for a scientific talk, but for the University of Arizona Cancer Center’s outreach team it was the perfect venue to introduce their inaugural scientific café. The center’s Community Outreach and Engagement office developed the scientific cafés in collaboration with the center’s Research Outreach for Southern Arizona. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UCSF Health has performed 150 robotic focal high-intensity focused ultrasound (HIFU) procedures for patients living with prostate cancer, becoming the first on the West Coast and the first UC Health System to reach that milestone. The HIFU technology uses ultrasound waves to destroy cancerous prostate tissue. Read More

Siteman Cancer Center The National Cancer Institute has awarded Washington University researchers at Siteman Cancer Center a $11.6 million Specialized Programs of Research Excellence (SPORE) grant. The five-year grant will fund research programs at Washington University, the University of New Mexico, and the University of Oklahoma Health Sciences Center. Read More

University of Florida Health Cancer Center The American Society of Hematology has selected Jonathan D. Licht, MD, director of the UF Health Cancer Center, as the inaugural editor-in-chief of one of the newest additions to the Blood Journals portfolio, Blood Neoplasia. He was selected by the ASH Executive Committee after a competitive international search. Read More

The AACI Physician Clinical Leadership Initiative (PCLI) will host "A Practical Approach to Building a Survivorship Program" at 1:00 pm eastern time on Tuesday, November 14. Survivorship care should be included as a standard of care for all cancer survivors. This presentation will review the core aspects of a survivorship program and considerations to make it sustainable. Pictured, clockwise from top right: Dr. Julie Vose, Dr. Laura Tenner, and Rachael Schmidt Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University How microbiota impact cancer development and therapy has become an expansive area of research. Although a few associations have garnered support from the scientific community, studies describing microbiota’s disease-causing and therapeutic contributions with many cancers are still very much in the early stages. Read More

Cedars-Sinai Cancer Joseph H. Schwab, MD, MS, an internationally recognized leader in the diagnosis and treatment of complex orthopaedic and spinal oncology conditions, has joined Cedars-Sinai as the new director of spine oncology for orthopaedic surgery and the director of the Center for Surgical Technology and AI Research. Read More

Wilmot Cancer Institute, UR Medicine Dan Mulkerin, MD, has been promoted to medical director and associate chief medical officer for Wilmot Cancer Institute. He joined the team at Wilmot two years ago from the University of Wisconsin Carbone Cancer Center. Read More

The Tisch Cancer Institute at Mount Sinai The National Cancer Institute has awarded the Icahn School of Medicine at Mount Sinai a $3.4 million grant to create a model that identifies the best prostate cancer treatment for people with HIV. Read More

The University of Kansas Cancer Center A new $11.5 million five-year federal grant will support researchers’ efforts to apply implementation science to ensure everyone benefits from the latest research advances. Implementation science aims to address the gap between what is known to be effective and what is actually done in the clinic. Read More

Duke Cancer Institute, Duke University Medical Center Angelo Moore, PhD, MSN, RN, NE-BC, director of the Duke Cancer Institute Office of Health Equity, has been named a Fellow of the American Academy of Nursing. Dr. Moore, along with four other nurses at Duke, is among 253 new fellows selected from across the country and internationally. Read More

Stanford Cancer Institute The Stanford Cancer Institute is establishing the Stanford Advanced Melanoma Program. This effort involves assembling a team of experts, addressing the shortage of clinical trials, unlocking the power of immunotherapy, and launching a dedicated advanced melanoma lab. Read More

Vanderbilt-Ingram Cancer Center As cells grow and divide, their DNA needs to be accurately replicated and properly segregated to new cells. Errors during replication or segregation can alter the genome and promote cancer. Now, researchers have identified the mechanism by which the enzyme and tumor suppressor SETD2 prevents the propagation of these errors, thus safeguarding the integrity of the genome. Read More

Roswell Park Comprehensive Cancer Center Initial results from an in-progress Roswell Park Comprehensive Cancer Center clinical trial offer important insights into hormone receptor-positive and HER2-negative (HR+/HER2−) metastatic breast cancer and patient response to CDK4/6 inhibitors. Read More

University of Florida Health Cancer Center The UF Health Cancer Center has announced that Alison M. Ivey, RN, MS, MBA, OCN, CCRP, has been promoted to associate director for administration and chief administrative officer at the UF Health Cancer Center. Erin Monari, PhD, CCRP, has been named administrative director of the Clinical Research Office. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Researchers at Baylor College of Medicine have developed a new compound called d16 that can reduce tumor growth and overcome therapeutic resistance in mutant p53-bearing cancers in the lab. Read More

UCLA Jonsson Comprehensive Cancer Center Three new cancer researchers have joined the UCLA Health Jonsson Comprehensive Cancer Center to spearhead initiatives aimed at advancing the understanding of cancer prevention and treatment: Mina Sedrak, MD, MS; Ya-Chen Tina Shih, PhD; and Paul Spellman, PhD. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center is pleased to announce the hiring of Sara Small, MD, PhD, as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies. Read More

University of Michigan Rogel Cancer Center An interdepartmental group of researchers at the University of Michigan Health Rogel Cancer Center received a grant from the National Cancer Institute's SPORE, or Specialized Program of Research Excellence, to further research on radiosensitization. Read More

UCSF Helen Diller Family Comprehensive Cancer Center In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin, and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies. Read More

WVU Cancer Institute Head and neck surgeons with WVU Medicine Otolaryngology and the WVU Cancer Institute have performed WVU Medicine’s first jaw reconstruction using a bone-containing thigh free flap to treat a patient with an aggressive form of oral cancer. Read More

USC Norris Comprehensive Cancer Center An international research team led by scientists in the Center for Genetic Epidemiology at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center has singled out mutations in 11 genes that are associated with aggressive forms of prostate cancer. Read More

Hollings Cancer Center, Medical University of South Carolina In a recently published paper, researchers showed that encoding the CAR T cells with instructions to create a hyperactive form of protein STAT5 prompted the CAR T cells to engraft, or take root and begin multiplying, without requiring lymphodepletion. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A five-year $3.04 million grant from the National Cancer Institute will help researchers at The Ohio State University Comprehensive Cancer Center – The James study the effectiveness of a new triple-target cellular therapy they have developed to more effectively treat patients with relapsed or treatment-resistant B-cell malignancies. Read More

Roswell Park Comprehensive Cancer Center A shining beacon of care, warmth, and hope to the patients and families who encounter her, Roswell Park Comprehensive Cancer Center’s Kimberly Sweeney, MBA, RN, has been appointed vice president of patient care experience. Read More

UAMS Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences researcher Amanda Stolarz, PharmD, PhD, recently received a five-year, $1.8 million grant from the National Cancer Institute (NCI). Dr. Stolarz is principal investigator on a study investigating possible prevention of a major complication from chemotherapy. Read More

UCLA Jonsson Comprehensive Cancer Center A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the brain from other parts of the body respond to immunotherapy while glioblastoma, an aggressive cancer that originates in the brain, does not. Read More

Vanderbilt-Ingram Cancer Center A molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients, according to a new study. Teams from three medical centers studied samples from a large group of patients with thyroid cancer to better understand thyroid cancer progression and to identify biomarkers for aggressive disease. Read More

University of Michigan Rogel Cancer Center New research reveals an alarming lack of access for non-English speakers who called hospitals across the United States looking for information on cancer care. University of Michigan Health Rogel Cancer Center researchers simulated patient calls to hospital general information lines, speaking English, Spanish, and Mandarin. Read More

Stanford Cancer Institute Stanford Cancer Institute member Millie Das, MD, was elected by the board of directors of the Association of Northern California Oncologists as its new president. A practicing thoracic oncologist, Dr. Das is chief of oncology at the Palo Alto VA, and clinical associate professor of medicine at Stanford University. Read More

The University of Arizona Cancer Center Researchers at the University of Arizona Cancer Center discovered a new class of iron-targeting compounds that hamper the proliferation of malignant cells. The discovery could lead to the development broad-spectrum, anticancer drugs that target iron metabolism. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center and Temple Health announce the hiring of Randall A. Lee, MD, as an assistant professor in the Department of Urology and a member of the Fox Chase-Temple Urologic Institute. Read More

Cedars-Sinai Cancer Hematologist/oncologist Kevin Scher, MD, MBA, an expert in patient-centric care with more than 10 years of experience on the Cedars-Sinai Cancer faculty, has been appointed medical director of Cedars-Sinai Cancer in Beverly Hills. Read More

Sidney Kimmel Cancer Center at Jefferson Health Hien Dang, PhD, is among an initial group of 11 early-career researchers who will receive five-year Cancer Moonshot awards to advance their work on cancers that affect socially disadvantaged populations most. Read More

Integra Connect offers oncology-specific solutions to improve care quality and research while also reducing costs with: Information from industry-leading specialty care data Insights from powerful AI and analytics solutions Intelligence from unprecedented experience and expertise Get tips from VBC experts. Watch Now

Association of American Cancer Institutes The AACI Physician Clinical Leadership Initiative (PCLI) will host "A Practical Approach to Building a Survivorship Program" at 1:00 pm eastern time on Tuesday, November 14. Panelists will review the core aspects of a survivorship program and considerations for sustainability. Pictured, clockwise from top right: Webinar panelists Dr. Julie Vose, Dr. Laura Tenner, and Rachael Schmidt Read More

Vanderbilt-Ingram Cancer Center Vanderbilt-Ingram Cancer Center (VICC) has earned a Merit Extension Award from the National Cancer Institute (NCI) in recognition of more than a decade of sustained exceptional progress. The Merit Extension Award provides two additional years of funding from the NCI Cancer Center Support Grant, adding $15 million to the $36 million grant that the NCI awarded to VICC in 2020. Ben Ho Park, MD, PhD, is the center's director. Read More

VCU Massey Comprehensive Cancer Center VCU Massey Comprehensive Cancer Center will present the 1st Annual Catchment Area Data (CADA) Conference: Beyond Definition, December 7-9, in Richmond, VA. The conference is open to AACI members and all eligible staff, faculty, students, and post-doc trainees from cancer centers who provide education, resources, and support within their defined catchment area. Registration closes Sunday, December 3. Read More

Andrew Mesecar, PhD, distinguished professor of biochemistry and the Walther Professor in Cancer Structural Biology, has been named assistant vice president for research and director of the Purdue Institute for Cancer Research after serving since August 2022 as interim director. Dr. Mesecar was chosen for the position after a nationwide search and his new role became effective September 1. Read More

University of Michigan Rogel Cancer Center A free online tool could save some prostate cancer patients more than $9,000 in out-of-pocket drug costs. Researchers from the University of Michigan Rogel Cancer Center found that the Medicare Part D Plan Finder, funded by the Centers for Medicare and Medicaid Services, can identify significant savings for patients taking abiraterone or enzalutamide for advanced prostate cancer. Read More

Fred Hutchinson Cancer Center Fred Hutchinson Cancer Center will be the national coordinating center for a new epidemiological cohort study among Asian Americans, Native Hawaiians, and Pacific Islanders. Fred Hutch was awarded a seven-year, $38.7 million National Institutes of Health grant to coordinate the effort to gather health information on these populations, which are underrepresented in biomedical research. Read More

Taofeek K. Owonikoko, MD, PhD, has been appointed executive director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). Dr. Owonikoko will also take on several faculty appointments at the University of Maryland School of Medicine, University of Maryland Medical Center, and the University of Maryland, Baltimore. He will begin his tenure in January 2024, taking over from Kevin J. Cullen, MD, who is stepping down as director after 20 years. Read More

AACI will hold the 2024 Leadership Diversity and Development Workshop (LDDW), March 11-13, at Loews Chicago O'Hare Hotel in Rosemont, IL. LDDW began as a component of the Leadership Diversity and Development Initiative (LDDI), the presidential initiative of AACI Immediate Past President Caryn Lerman, PhD, director of USC Norris Comprehensive Cancer Center. Read More

Roswell Park Comprehensive Cancer Center A program launched at Roswell Park Comprehensive Cancer Center three years ago to advance health equity and access by strengthening connections between cancer researchers and Indigenous communities has grown into a broad-based team of Indigenous experts with an expanded scope and purpose. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The Ohio State University has been awarded a $20 million Tobacco Center of Regulatory Science grant from the U.S. Food and Drug Administration. The grant is a collaboration of experts from the colleges of medicine, public health, and law organized and implemented through the Center for Tobacco Research at OSUCCC James. Read More

Siteman Cancer Center Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital have established a comprehensive Head & Neck Tumor Center at Siteman Cancer Center. Among the first of its kind in the country, the center emphasizes individualized, patient-centered care with complementary research programs. Read More

Stanford Cancer Institute Stanford Cancer Institute member Reena Thomas, MD, PhD, was awarded nearly $12 million from the California Institute for Regenerative Medicine for a Phase I clinical research trial to assess the safety of a CAR T-cell immunotherapy for glioblastoma multiforme. Read More

UCSF Helen Diller Family Comprehensive Cancer Center With a renewed Specialized Program of Research Excellence (SPORE) grant, the UC San Francisco Brain Tumor Center is receiving $12 million over five years to translate scientific findings into improved care for people with brain tumors. The award marks the fifth cycle of continuous support for the UCSF Brain Tumor SPORE program since the National Cancer Institute (NCI) first established brain tumor SPOREs in 2002. Read More

UK Markey Cancer Center The University of Kentucky will host a new research center, the Appalachian Tobacco Regulatory Science Team, focused on tobacco regulations and funded with a $19 million grant. As part of an interagency partnership, the National Institutes of Health and the U.S. Food and Drug Administration award Tobacco Centers of Regulatory Science grants that support studies across topics like toxicity, addiction, health effects, and marketing. Read More

University of Michigan Rogel Cancer Center The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment. Pioneered at the University of Michigan, histotripsy offers a promising alternative to cancer treatments such as surgery, radiation and chemotherapy, which often have significant side effects. Read More

Hollings Cancer Center, Medical University of South Carolina MUSC Hollings Cancer Center has recruited Thai Ho, MD, PhD, to lead the development of the Precision Oncology Program and a precision oncology tumor board. Dr. Ho treats patients with genitourinary cancers and runs a lab focused on researching a mutation in the gene SETD2 that occurs in kidney cancer. Read More

University of Hawai'i Cancer Center, University of Hawai'i at Mānoa A $10.9 million grant from the National Institutes of Health will help establish the UH Pacific Center for Genome Research. It's part of a nationwide effort to advance diversity in genomics research through innovative, state-of-the-art studies to ultimately improve diagnosis and treatment for minority ethnic groups that have long experienced health disparities. Read More

Siteman Cancer Center The National Cancer Institute has awarded Washington University researchers at Siteman Cancer Center a $10.9 million Specialized Programs of Research Excellence (SPORE) grant. The five-year grant will fund the development of new therapies for pancreatic ductal adenocarcinoma, the deadliest form of pancreatic cancer. Read More

The Tisch Cancer Institute at Mount Sinai Miriam Merad, MD, PhD, an immunologist at the Icahn School of Medicine at Mount Sinai, has been elected to the National Academy of Medicine in recognition of her pioneering contributions to the fields of immunology and cell biology. Read More

Moffitt Cancer Center The Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center has received a $10.4 million grant to study the eco-evolutionary dynamics responsible for non-small cell lung cancer growth and treatment resistance. The five-year Cancer Systems Biology Consortium Research Center grant will support two multitier research projects, two research support cores, and an innovative outreach core. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Two five-year grants totaling more than $6 million from the National Cancer Institute will help The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute researchers and colleagues at other institutions better understand acute myeloid leukemia genetics and the role of inflammation in regulating immune response t…

Sidney Kimmel Cancer Center at Jefferson Health The Philadelphia Communities Conquering Cancer (PC3) coalition consists of the Sidney Kimmel Cancer Center at Jefferson Health; Abramson Cancer Center of the University of Pennsylvania; and Fox Chase Cancer Center, Temple Health. A conference held this summer brought together key stakeholders to create a city-wide research roadmap for the three cancer centers to tackle cancer disparities in Philadelphia. Read More

UCLA Jonsson Comprehensive Cancer Center A team of investigators from the UCLA Jonsson Comprehensive Cancer Center and the UCLA School of Dentistry received a five-year $4.6 million grant from the National Cancer Institute to develop and improve liquid biopsy technologies for the early detection of lung cancer. Read More